Drug Discovery

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

February 22, 2018

Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA SHANGHAI, 22 Feb 2018: STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, and Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery […]

Certara Launches Version 10 of D360, Its Industry-leading Drug Discovery Informatics Platform

February 14, 2018

D360 v10 delivers powerful and intuitive visualization and data presentation tools embedded into the informatics platform, enabling faster and deeper data understanding Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of version 10 of D360™, its data informatics platform for discovery scientists. D360 is a self-service data access, […]

ADC Bio developing downstream bioconjugation process

February 12, 2018

New manufacturing paradigm will save 25% of total costs and Specialist Process Innovation Group created to validate approach 12 February 2018, Wales:ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing. In contrast to the existing approaches – which […]

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

January 31, 2018

Start-ups working on a range of technologies and discoveries – from AI to immunotherapy – receive complimentary access to Elsevier’s information solutions to accelerate innovation Elsevier, the global information analytics business specializing in science and health, today announced that six start-up companies have been selected from more than 150 global applicants for The Hive, Elsevier’s innovation initiative for biotech and pharmaceutical start-ups. Exscientia, LegoChem Biosciences, 4P-Pharma, […]

X-Chem, AstraZeneca Expand Drug Discovery Partnership

January 18, 2018

X-Chem, a small molecule discovery specialist, has expanded its existing global drug discovery and technology transfer collaboration with AstraZeneca.   The new agreement focuses on the synthesis and delivery of custom libraries to AstraZeneca as well as the transfer of the DEX platform, allowing for in-house screening of DNA-encoded libraries at AstraZeneca.   It is […]

Japanese pharma: No longer ‘lost in translation’

January 15, 2018

Amsterdam, 15th January 2018: A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead of what is likely to be the largest ever CPhI Japan (18-20 April, 2018) – has identified that demographic pressures […]

FEEDBACK